Home/Pipeline/Centhaquine (Lyfaquin®)

Centhaquine (Lyfaquin®)

Hypovolemic Shock

Approved (India)Commercial

Key Facts

Indication

Hypovolemic Shock

Phase

Approved (India)

Status

Commercial

Company

About Pharmazz

Innovative biotech delivering endothelin‑based drugs for critical care and neuroscience.

View full company profile

Therapeutic Areas

Neuroscience Cardiovascular Critical Care